Sukmayati Alegantina
Pusat Biomedis dan Teknologi Dasar Kesehatan, Badan Litbangkes, Kemenkes RI

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Kualitas Ekstrak Etanol 70% Daun Kelor (Moringa oleifera Lamk) dalam Ramuan Penambah ASI Sukmayati Alegantina; Ani Isnawati; Lucie Widowati
Jurnal Kefarmasian Indonesia VOLUME 3, NOMOR 1, FEBRUARI 2013
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (391.731 KB)

Abstract

From the collection of data (SDKI) in 2002-2003, it is found that the number of exclusive breastfeeding in infants below the age of two months covers only 64% of total infants. The most alarming facts are that 13% of infants under two months have been fed infant milk formula and one of three infants aged 2-3 months has been given additional food. Therefore, using Kelor as herba to facilitating breast milk is needed as extract requirement. In addition, this research considers characterization of Kelor extract as a first step to standardize Kelor extract. Sample is extract of Kelor leaf from East Java. To ensure quality requirements of 70% ethanol extract from Kelor leaf for herbal medicine, it has to meet the quality requirement guidelines established by BPOM. Examination includes non-specific parameter such as water content, total ash, total acid insoluble ash, and extract microscopic examination. In the other side, specific parameter includes content of dilute alkohol, content of dilute water, assay of total alkaloid and chemistry compound test. Characteristic of 70 % ethanol extract from Kelor leaf for non-specific parameter are water content 15,68%, total ash 3,04%, total acid insoluble ash 1,13% and loss on drying 29,70% , whereas characteristic of spesific parameter for content of dilute etanol 33,11%, content of dilute water 47,53%, and assay Trigonellin 15,68 %. The conclusion is non spesific characteristic from kelor leaf etanol extract, that is water content does not meet the quality requirement guidelines
Uji Mutagenik Ames untuk Melengkapi Data Keamanan Ekstrak Gambir (Uncaria gambir Roxb.) Novi Sulistyaningrum; Sukmayati Alegantina; Lina Rustanti
Jurnal Kefarmasian Indonesia VOLUME 3, NOMOR 1, FEBRUARI 2013
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (242.657 KB)

Abstract

The main compound of Uncaria gambir Roxb. (gambir), catechin and it’s derivates have been believed to be potential as antiviral. Epigallocatechin gallate (EGCG) and epicatechin are catechin derivates which are found to be potential as antiviral against Human Immunodeficiency Virus (HIV). However, gambir extract also contains quercetin that has possibility to be mutagenic. Therefore, a preliminary study towards safety of those compounds within gambir extract, mutagenicity assay using Ames Method has been performed.Sample (gambir extract) was obtained from West Sumatera, Indonesia. The extract was characterized according to Farmakope Herbal Indonesia and WHO methods. Mutagenicity test by Ames method utilized a colorimetric microplate in 6 various concentration (125 mg/mL; 62.5 mg/mL; 31.25 mg/mL; 15.625 mg/mL; 7.81 mg/mL dan 3.91 mg/mL) against mutant bacteria Salmonella typhimurium TA 98, Salmonella typhimurium TA 100 and Escherichia coli WP2 uvrA with and without the addition of S-9 enzyme. Extract of gambir in this study contains 86.60% of catechin, 12.92% moisture content, 22.49% water-soluble extract content, 80.63% ethanol-soluble extract content, 0.81% total ash, 0.32% acid insoluble ash content and 10.38% in dryness level. From the mutagenicity test and calculation, fold increase (over baseline) of the sample in 6 various concentration with and without adding S-9 enzyme are lower than 2. Gambir extract from West Sumatra with catechin contains 86.6% hasn’t showed mutagenic effect due to the fold increase (over baseline) of mutagenicity test lower than 2.